WASHINGTON, April 15, 2009 News media covering the chemical sciences, small businesses, and entrepreneurships are invited to join an American Chemical Society (ACS) Small & Medium Business Webinar Series on technology commercialization in lean times.
Scheduled for Thursday, April 23 from 2 3 p.m. Eastern Time, the teleconference will feature Craig Galbraith, MBA, Ph.D., Professor of Entrepreneurship and Technology Management and the GlaxoSmithKline Faculty Fellow in Economic Development at the Cameron School of Business at University of North Carolina in Wilmington. Galbraith is also an active private equity "angel" investor, works with numerous Department of Defense technology transfer agencies specializing in bio/chem warfare agent detection and port security technologies, and is currently the Vice-President of Commercialization for Horizon Vision Research, Inc., a start-up medical instruments R&D firm.
The topic for the teleconference is "Steps to successful technology commercialization for scientist entrepreneurs and small/medium businesses in lean times." Galbraith will discuss how to bring chemical/biopharma technology to commercialization in today's economy for entrepreneurs and small businesses
The ACS Small & Medium Business Webinar Series addresses current topics of interest to entrepreneurs and small & medium businesses in the chemical/biopharma enterprise. There will be a 30-minute presentation with Galbraith followed by a 25-minute Q & A session.
News media can tune into the conference without charge, but must register in advance at the ACS Industry Member Program Web site, which also provides information about future speakers. For additional information about upcoming speakers, click on the Small & Medium Business tab located at the top of the ACS Industry Member Programs page.
|Contact: Michael Bernstein|
American Chemical Society